S. S. Chaudhaery

发表

Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors.

V. Poroikov, A. Saxena, D. Filimonov, 2012, European journal of medicinal chemistry.

16α‐Hydroxycleroda‐3,13 (14)Z‐dien‐15,16‐olide from Polyalthia longifolia: a safe and orally active antileishmanial agent

A. Saxena, Awanish Kumar, Reema Gupta, 2010, British journal of pharmacology.

Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology.

Aamir Nazir, Chandishwar Nath, A. Saxena, 2010, Journal of medicinal chemistry.

Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach

V. Saini, Yousuf Ansari, S. Yasmin, 2019, International Journal Bioautomation.

Consensus Superiority of the Pharmacophore-Based Alignment, Over Maximum Common Substructure (MCS): 3D-QSAR Studies on Carbamates as Acetylcholinesterase Inhibitors

Anil K. Saxena, Kuldeep K. Roy, Shailendra S. Chaudhaery, 2009, J. Chem. Inf. Model..

Cloning, overexpression and characterization of Leishmania donovani squalene synthase.

A. Saxena, P. Bhargava, U. Roy, 2010, FEMS microbiology letters.

Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors

A K Saxena, S Saxena, S S Chaudhaery, 2010 .

Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors

A K Saxena, S Saxena, S S Chaudhaery, 2010, SAR and QSAR in environmental research.

N-substituted [phenyl-pyrazolo]-oxazin-2-thiones as COX-LOX inhibitors: influence of the replacement of the oxo -group with thioxo- group on the COX inhibition activity of N-substituted pyrazolo-oxazin-2-ones

A. Saxena, A. Geronikaki, P. Eleftheriou, 2010 .